Pörssitiedote16.12.2025 klo 7.57Chordate Medical terminates the liquidity guarantee for the common share
Pörssitiedote8.12.2025 klo 15.30Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Pörssitiedote18.11.2025 klo 18.40Notice to the Extraordinary General Meeting in Chordate Medical Holding AB (publ)
Pörssitiedote18.11.2025 klo 18.30The board of directors of Chordate proposes that the general meeting resolves on voluntary liquidation and delisting
Lehdistötiedote19.8.2025 klo 6.30Chordate reports preliminary conclusions from long-term study on chronic migraine: PM010
Pörssitiedote17.7.2025 klo 13.45Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Pörssitiedote30.6.2025 klo 16.45Notice of Extraordinary General Meeting of Chordate Medical Holding AB (publ)
Pörssitiedote30.6.2025 klo 16.30Chordate decides on a conditional directed new issue of Preference Shares of approximately SEK 2.55 million
Lehdistötiedote27.6.2025 klo 6.30Chordate presents conclusions from the second data monitoring of the ongoing open-label long-term study on chronic migraine: PM010
Pörssitiedote21.5.2025 klo 14.15Communiqué from the Annual General Meeting of Chordate Medical Holding AB (publ)
Lehdistötiedote20.5.2025 klo 9.00BioStock: BioStock: New distributor strengthens Chordate Medical’s investment in Saudi Arabia
Lehdistötiedote13.5.2025 klo 8.45Chordate Medical Expands Migraine Offering in Saudi Arabia – Appoints Additional Distributor
Pörssitiedote7.5.2025 klo 8.55Chordate Medical terminates the liquidity provider agreement for the preference share